Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…n. It is noticed that two patients switched from ocrelizumab to ofatumumab: one due to infusion-related adverse effects and another for lo…
…allenges when pregnancy is planned. Anti-CD20 therapies such as ofatumumab are effective; however, their safety during pregnancy remains u…
…sess disability outcomes (up to 7 years) of early initiation of ofatumumab treatment versus delayed treatment (after switching from terifl…
… 6 years, supporting the favourable long-term safety profile of ofatumumab in pwRMS.…
… responded well to high-dose corticosteroids and was started on ofatumumab as disease-modifying therapy. Baseline laboratory investigation…
…re assessed every 6–12 months.Results 195 patients treated with ocrelizumab or ofatumumab, with a mean age of 49.1 (±12.4) years, were foll…
…nfants, most were breastfed on natalizumab (n=125), followed by ocrelizumab (n=34), rituximab (n=11) and ofatumumab (n=10); three had multi…